GIBRAN NADDY: Open Payments
NPI 1962470567 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,459 in 81 payments from 20 companies in 2025. Trend: 2023 $1,534 · 2024 $1,406 · 2025 $1,459
Food & beverage: $1,459
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $264 |
| AstraZeneca Pharmaceuticals LP | 13 | $247 |
| Novartis Pharmaceuticals Corporation | 9 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $139 |
| Corcept Therapeutics | 5 | $102 |
| Lilly USA, LLC | 5 | $102 |
| JAZZ PHARMACEUTICALS INC. | 2 | $60 |
| PFIZER INC. | 3 | $57 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
Products named: LEQVIO, AIRSUPRA, OTEZLA, Kerendia, EVENITY, Korlym, MOUNJARO, XYWAV.
Industry payments across TN — which companies pay providers there.
